Dr. Farzad Najam Will Assist the Development of InferX Prospective Core Measure Tracking (PCMT) SystemSTERLING, Va., Oct. 6 /PRNewswire-FirstCall/ — InferX Corporation (Pink Sheets: NFRX) today announced that it has added Dr. Farzad Najam to its Board of Advisors. Dr. Najam will advise the executive management team on healthcare issues concerning hospital quality care and will assist in the development of the Prospective Core Measure Tracking (PCMT) System, the flagship solution in the InferX healthcare solution set.
"We are pleased to have a leader such as Dr. Farzad Najam advising InferX on the development of our healthcare solutions," said B.K. Gogia, InferX Chairman & CEO. "Dr. Najam recognized early on that improving the quality of healthcare delivery and patient safety is paramount to any healthcare solution. Today a majority of the hospitals are embracing new offerings which can reduce the burden of Core Measure reporting to meet new requirements imposed by the Joint Commission and Center for Medicare and Medicaid Services (CMS). We are very excited to be working with him in this endeavor."
"There are no predictive analytics solutions available in medicine today and if there were, we could prevent the many complications which hinder the quality of healthcare," said Dr. Najam. "The InferX PCMT provides a way to foresee events in medicine that would significantly improve the delivery of healthcare in the hospitals across the globe."
Using InferX advanced analytics and dashboard technology, InferX believes that clinical patterns can be identified that will lead to prevention of medical errors and prediction of unexpected events leading to intervention. It is a patented system which will offer hospitals a fully integrated system that is designed to reduce morbidity and mortality, improve patient care, reduce costs, and improve efficiency while increasing profits, minimizing risk and increasing patient satisfaction.